More Smart Savings From ASHP Meeting Pharmacy Practice News That means that, in many cases, recipients require higher levels of induction agents, such as antithymocyte globulin (ATG) and basiliximab (Siumulect, Novartis) than those who receive nonmarginal kidneys. “When you combine the high cost of these drugs ... |
